Search clinical trials for: Alogliptin and Pioglitazone

Total 272061 results

Merck Sharp & Dohme LLC

Completed

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

Type 2 Diabetes Mellitus
Takeda

Completed

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome (EXAMINE)

Diabetes Mellitus, Type 2 | Acute Coronary Syndrome

United States, France, Italy, Poland, Ukraine, United Kingdom, Belgium, Germany, Hong Kong, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, Malaysia, Romania, Serbia, South Africa, Japan, Canada, Finland, Taiwan, Korea,... and more
Takeda

Completed

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Diabetes Mellitus

United States, Poland, Ukraine, Israel, Mexico, Romania, South Africa, Peru, Russian Federation, Hungary, India
Takeda

Completed

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Diabetes Mellitus

Japan
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States, France, United Kingdom
Takeda

Completed

Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants

Pharmacokinetics and Pharmacodynamics

Korea, Republic of
Takeda

Completed

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Poland, Germany, Argentina, South Africa, Netherlands, Peru, Czech Republic, Brazil, Chile, Guatemala, Dominican Republic
Royal Devon and Exeter NHS Foundation Trust
King's College London; Newcastle University; NHS Tayside; University of Dundee; University... and other collaborators

Completed

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes. (TriMaster)

Type 2 Diabetes

United Kingdom
Nathan Kline Institute for Psychiatric Research

Completed

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Diabetes | Schizophrenia | Cognitive Impairment | Insulin Resistance

United States
Sanofi

Completed

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone (GETGOAL-P)

Diabetes Mellitus Type 2

United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
Bangabandhu Sheikh Mujib Medical University, Dhaka...
Aristopharma Ltd

Recruiting

Effectiveness of Tofacitinib in Systemic Sclerosis

Efficacy of Tofacitinib in the Systemic Sclerosis

Bangladesh
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

PPARγ Agonist Treatment for Cocaine Dependence

Alcohol Use Disorder | Cocaine Use Disorder

United States
Takeda

Completed

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Clinical Pharmacology

Japan
Takeda

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution

Japan
Takeda

Completed

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
JW Pharmaceutical

Active, not recruiting

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM (SSUG)

Type 2 Diabetes Mellitus

Korea, Republic of
Henry Ford Health System

Completed

Topical Capsaicin for Cyclical Vomiting

Cyclical Vomiting

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy

Head and Neck Cancer | Radiation Toxicity

United States
Takeda

Completed

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. (CHICAGO)

Diabetes Mellitus

United States
Takeda

Completed

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus (PERISCOPE)

Diabetes Mellitus

United States, Argentina, Canada, Chile
Baylor College of Medicine

Completed

Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes

Type 2 Diabetes Mellitus

United States
Pusan National University Hospital

Unknown

Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Seoul National University Hospital

Recruiting

Anesthesia and Acute Kidney Injury After Nephrectomy

Nephrectomy

Korea, Republic of
Takeda

Withdrawn

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Takeda

Completed

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Diabetes Mellitus
Pennington Biomedical Research Center

Completed

A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS (TAKE II)

Diabetes Mellitus

United States
Cairo University

Completed

Ovulation Induction in Clomiphene Citrate Resistant PCO Women

Polycystic Ovary Syndrome | Infertility

Egypt
Boehringer Ingelheim

Completed

Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers

Healthy
Stanford University

Terminated

Insulin Resistance in Pulmonary Arterial Hypertension

Hypertension, Pulmonary

United States
University of Chicago
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Terminated

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

Polycystic Ovary Syndrome | Obstructive Sleep Apnea

United States
Takeda

Completed

Phase 1 Bioavailability Study of SYR-322MET

Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.

Unknown

A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

Alzheimer Disease

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Aichi Gakuin University

Unknown

Effects of Alogliptin on Pancreatic Beta Cell Function

Diabetes Mellitus, Type 2

Japan
University of Basrah

Recruiting

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

Type2diabetes

Iraq
Takeda

Completed

Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus (ENDURE)

Type 2 Diabetes Mellitus

United States, Poland, Ukraine, United Kingdom, Mexico, Spain, Romania, Israel, Canada, New Zealand, Singapore, Russian Federation, Chile, Puerto Rico, Thailand, Hungary, Austria, Lithuania, Malaysia, Philippines, Australia, India, South... and more
University of California, San Diego

Withdrawn

Study the Relationship Between Obesity and Hepatitis C Replication

Hepatitis C

United States, Egypt
Khyber Medical University Peshawar

Completed

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

PCOS

Pakistan
Baylor College of Medicine

Completed

Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

Type 2 Diabetes Mellitus

United States
Takeda

Completed

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Type 2 Diabetes Mellitus

Japan
Eli Lilly and Company

Completed

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-1)

Diabetes Mellitus, Type 2

United States, Argentina, Puerto Rico, Mexico
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Recruiting

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

Cocaine Use Disorder

United States
Centre Francois Baclesse
Canceropôle Nord Ouest

Completed

Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study (CHOCOLATE)

Thyroid Gland

France
National Institute of Diabetes and Digestive and...

Completed

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) (PIVENS)

Liver Diseases

United States
Vomaris Innovations

Completed

Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

Acute Wounds

United States
Takeda

Completed

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan

Diabetes Mellitus, Type 2

Japan
University of Regensburg
ClinAssess GmbH

Unknown

Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial (MM03)

Multiple Myeloma

Germany
Bayside Health

Completed

Determining the Effect of Abacavir on Platelet Activation

Cardiovascular Disease | HIV

Australia
Nagaoka Red Cross Hospital
Kurume University

Unknown

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Dong-A ST Co., Ltd.

Completed

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Type2 Diabetes

Korea, Republic of

Search clinical trials for: Alogliptin and Pioglitazone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations